BMS Foundation launches national programme to bolster mental health diversion initiatives: Lawrenceville, New Jersey Saturday, January 17, 2026, 12:00 Hrs [IST] The Bristol Myers ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Investing in dividend stocks, which can help boost returns through dividend reinvestment, is particularly good, as they have ...

In this technology explainer, learn how to safeguard operations with integrated DC UPS, battery management and ultracapacitor ...

After 46 years, the Danish Viper has stood down from duty, but survivors will continue to fly in Argentina and Ukraine.

This time, Tecvayli excelled as a solo agent, reducing the risk of disease progression or death by 71% over standard of care ...

BRUNSWICK, Ohio -- The snow was kind of hiding Hinckley Lake, but my great-grandson and I headed over to see if it was ...

Recent changes at the Kennedy Center highlight an executive misunderstanding about the arts and what they’re for.

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

The consequences of President Trump's actions on drug pricing continue to play out, with Bristol Myers Squibb insisting it will charge the same in the UK for new schizophrenia drug Cobenfy as in the ...

A new study led by MUSC Hollings Cancer Center researchers Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., sheds light on why ...

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and ...